Xiongfei Yu

1.5k total citations · 1 hit paper
33 papers, 972 citations indexed

About

Xiongfei Yu is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiongfei Yu has authored 33 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiongfei Yu's work include Cancer-related molecular mechanisms research (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xiongfei Yu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xiongfei Yu collaborates with scholars based in China, United States and Madagascar. Xiongfei Yu's co-authors include Haiyong Wang, Lisong Teng, Yimin Lu, Haohao Wang, Lisong Teng, Zhongqi Li, Zhengfu Ning, Wentong Zhang, Qing Wang and Zhilin Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Science and Medicine.

In The Last Decade

Xiongfei Yu

30 papers receiving 959 citations

Hit Papers

Revealing the transcriptional heterogeneity of organ‐spec... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiongfei Yu China 15 455 306 279 164 147 33 972
С. И. Филиппов United States 9 451 1.0× 392 1.3× 137 0.5× 90 0.5× 461 3.1× 18 1.3k
Alejandro Sánchez United States 12 276 0.6× 135 0.4× 213 0.8× 450 2.7× 115 0.8× 56 722
Jinghe Li China 20 511 1.1× 232 0.8× 269 1.0× 131 0.8× 125 0.9× 58 976
Xiang Zhao China 20 358 0.8× 226 0.7× 176 0.6× 76 0.5× 200 1.4× 64 1.0k
Chi‐Kuan Chen Taiwan 16 462 1.0× 149 0.5× 173 0.6× 90 0.5× 68 0.5× 40 1.0k
Quanxing Liu China 21 261 0.6× 152 0.5× 185 0.7× 418 2.5× 243 1.7× 62 969
Jianming Zheng China 22 627 1.4× 452 1.5× 378 1.4× 166 1.0× 157 1.1× 86 1.5k
Chenglin Guo China 19 560 1.2× 326 1.1× 230 0.8× 377 2.3× 158 1.1× 95 1.3k
Shinsuke Sasada Japan 19 121 0.3× 168 0.5× 203 0.7× 320 2.0× 127 0.9× 91 955
Yong Xu China 19 212 0.5× 82 0.3× 337 1.2× 550 3.4× 113 0.8× 102 1.2k

Countries citing papers authored by Xiongfei Yu

Since Specialization
Citations

This map shows the geographic impact of Xiongfei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongfei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongfei Yu more than expected).

Fields of papers citing papers by Xiongfei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiongfei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongfei Yu. The network helps show where Xiongfei Yu may publish in the future.

Co-authorship network of co-authors of Xiongfei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiongfei Yu. A scholar is included among the top collaborators of Xiongfei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiongfei Yu. Xiongfei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Lin, Yingzi Zhang, Yan Yang, et al.. (2023). Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis. Advanced Science. 10(30). e2303908–e2303908. 33 indexed citations
4.
Yu, Xiongfei, Yiran Chen, Jun Lü, et al.. (2022). Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study. Frontiers in Oncology. 12. 985154–985154. 6 indexed citations
5.
Yang, Yan, Yingying Huang, Lin Wu, et al.. (2022). Host miRNAs-microbiota interactions in gastric cancer. Journal of Translational Medicine. 20(1). 52–52. 8 indexed citations
6.
Sun, Ting, Chenyu Mao, Xiongfei Yu, et al.. (2020). <p>The Ectopic Expression of SurvivinT34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer</p>. OncoTargets and Therapy. Volume 13. 1011–1025. 6 indexed citations
7.
Ding, Yongfeng, Yanyan Chen, Mengjie Wu, et al.. (2020). Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer. Oncology Letters. 20(1). 215–225. 12 indexed citations
8.
Zhang, Junbin, et al.. (2020). <p>Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer</p>. Cancer Management and Research. Volume 12. 2767–2775. 14 indexed citations
9.
Cheng, Zhilin, Zhengfu Ning, Xiongfei Yu, Qing Wang, & Wentong Zhang. (2019). New insights into spontaneous imbibition in tight oil sandstones with NMR. Journal of Petroleum Science and Engineering. 179. 455–464. 103 indexed citations
10.
Pan, Jun, Hui Li, Feng Zhu, et al.. (2018). Regeneration of a Bioengineered Thyroid Using Decellularized Thyroid Matrix. Thyroid. 29(1). 142–152. 13 indexed citations
11.
Wang, Shao-Cheng, Yanyan Chen, Xiongfei Yu, et al.. (2018). miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer. Pathology - Research and Practice. 215(4). 676–682. 43 indexed citations
12.
Yu, Xiongfei, Haohao Wang, Haiyong Wang, et al.. (2015). Advances in the targeted therapy of liposarcoma. OncoTargets and Therapy. 8. 125–125. 22 indexed citations
13.
Yu, Xiongfei. (2015). Gastritis cystica profunda in a previously unoperated stomach: A case report. World Journal of Gastroenterology. 21(12). 3759–3759. 13 indexed citations
14.
Yu, Xiongfei, et al.. (2013). Prognostic Role of C-reactive Protein in Gastric Cancer: A Meta-analysis. Asian Pacific Journal of Cancer Prevention. 14(10). 5735–5740. 40 indexed citations
15.
Chen, Xin, Zhongqi Li, Xiongfei Yu, et al.. (2013). Indocyanine green clearance in evaluating the recovery of liver reserve function after superselective transarterial chemoembolization. Hepatobiliary & pancreatic diseases international. 12(6). 656–660. 8 indexed citations
16.
Li, Guangliang, Jing Zhang, Ketao Jin, et al.. (2013). Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Molecular Oncology. 7(3). 611–624. 62 indexed citations
17.
Yang, Rong, Xiongfei Yu, Liang Ma, & Fusheng Wu. (2012). Emergency management of a patient with severe airway obstruction resulting from poorly differentiated thyroid carcinoma: A case report. Oncology Letters. 4(4). 771–774. 5 indexed citations
18.
Wang, Weibin, Wenhe Zhao, Haiyong Wang, et al.. (2011). Poorer Prognosis and Higher Prevalence of BRAF V600E Mutation in Synchronous Bilateral Papillary Thyroid Carcinoma. Annals of Surgical Oncology. 19(1). 31–36. 47 indexed citations
19.
Li, Zhongqi, Ketao Jin, Xiongfei Yu, et al.. (2011). Extranodal follicular dendritic cell sarcoma in mesentery: A case report. Oncology Letters. 2(4). 649–652. 18 indexed citations
20.
Wu, Fusheng, et al.. (2004). Malignant gastric carcinoids with liver metastasis.. PubMed. 3(3). 406–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026